MEDICINE DETAILS
Vegzelma
Active ingredient: Bevacizumab Adcd
Neutral reference profile for an independent medicine-access consultancy enquiry about Vegzelma (Bevacizumab Adcd). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Vegzelma used for?
On September 28, the U.S. Food and Drug Administration (FDA) approved bevacizumab-adcd (Vegzelma), a biosimilar to bevacizumab (Avastin), for the treatment of six types of cancer: metastatic colorectal cancer; recurrent or metastatic nonsquamous non–small cell lung cancer (NSCLC); recurrent glioblastoma; metastatic renal cell carcinoma; persistent, recurrent, or metastatic cervical cancer; and epithelial ovarian, fallopian tube, or primary peritoneal cancer.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Vegzelma identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
25 mg/ml (100 mg total) · 1 vial Catalogue organisation: Celltrion Healthcare Deutschland GmbH
-
25 mg/ml (400 mg total) concentrate for solution for infusion · 1 vial Catalogue organisation: Abacus Medicine A/S
OFFICIAL SOURCES
Check the Vegzelma record at an official source.
Search for “Vegzelma” or “Bevacizumab Adcd”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Vegzelma.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Vegzelma
01What is Vegzelma?＋
This directory record associates the brand name Vegzelma with the active ingredient Bevacizumab Adcd. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Vegzelma strengths and packs are recorded?＋
The catalogue currently shows: 25 mg/ml (100 mg total) · 1 vial; 25 mg/ml (400 mg total) concentrate for solution for infusion · 1 vial. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Vegzelma?＋
Catalogue records currently name: Celltrion Healthcare Deutschland GmbH, Abacus Medicine A/S. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Vegzelma?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Vegzelma, payment request, stock guarantee or binding offer.
06Can I buy Vegzelma from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.